Trinity Biotech plc, a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced the appointment of Adrian Donohue as Chief Commercial Officer. Mr. Donohue brings more than 25 years of experience in the sales and marketing of healthcare products.
John Gillard, President and Chief Executive Officer of Trinity Biotech, said, “We are resolute in continuing to execute on our transformation agenda, which will drive greater performance and profitability in our existing product lines, including supporting continued growth in our newest rapid HIV testing product, TrinScreen HIV. Adrian’s appointment to this important leadership role and responsibility for our entire portfolio is a critical step to achieve this commitment and we are delighted to have him join the team.”
Commenting on his appointment, Adrian Donohue said, “It’s an exciting time to be joining Trinity Biotech as it executes on a comprehensive transformation plan and positions itself to be a global competitor in the continuous glucose monitor (CGM) market. I look forward to driving the potential of our extensive range of products to deliver significant benefits to our customers and the patients they serve. I am also eager to begin preparations for the international launch of our innovative CGM.”
Also Read: Momentum & Cube Biotech Announce Strategic Partnership
Throughout this career Mr. Donohue developed a strong reputation as a successful sales and marketing executive with keen business and commercial acumen, particularly with regard to successful launches of life science products in EMEA and more recently Japan. Mr. Donohue is known as an effective team builder and leader, through his natural engagement and influencing skills. He has a passion for innovation and cutting-edge development and his collaborative style facilitates a productive working culture. These strengths combine with a fresh and innovative approach to developing and delivering on commercial strategies.
Mr. Donohue has more than 25 years of experience in sales and marketing of healthcare products. Adrian developed his knowledge and early career success as a sales representative for Menarini, Eli Lilly and Roche. He then broadened his commercial experience as Senior Brand Manager at Shire Pharma for six years. Mr Donohue moved on to the role of EMEA Franchise lead at Biomarin for nearly a decade, which led to his promotion to Global Senior Director in 2022. Mr. Donohue has a primary degree from the University College Dublin and Post Grad Entrepreneurial Studies at Smurfit School of Business.
SOURCE: GlobeNewswire